Bupa Finance plc publishes prospectuses in relation to its offering of £300 million Fixed Rate Notes due 2027 and £350 million Fixed Rate Subordinated Notes due 2035

23 June 2020 . International

Bupa Finance plc today announces that it has published prospectuses in relation to its £300 million 1.750 per cent. fixed rate notes due 2027 (the “Senior Notes) and its £350 million 4.125 per cent. fixed rate subordinated notes due 2035 (the “Tier 2 Notes”) (together the "Prospectuses").

The Prospectuses have been approved by the Financial Conduct Authority and are now available for viewing. To view the full documents, please click here:

www.rns-pdf.londonstockexchange.com/rns/8370Q_1-2020-6-23.pdf

and

www.rns-pdf.londonstockexchange.com/rns/8370Q_2-2020-6-23.pdf.

The Prospectuses have been submitted to the National Storage Mechanism and will shortly be available for inspection at:  https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The Senior Notes and the Tier 2 Notes will be issued by Bupa Finance plc on 25 June 2020. The Senior Notes are guaranteed by The British United Provident Association Limited (“Bupa”).

Investors

Investor Relations: ir@bupa.com

Media

 

Rupert Gowrley (Corporate Affairs): rupert.gowrley@bupa.com

 

DISCLAIMER

This announcement is for information purposes only and does not constitute an offer to sell or the solicitation of an offer to buy the Senior Notes and the Tier 2 Notes (together “the Notes”) or any other security and shall not constitute an offer, solicitation or sale in the United States or in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful.

Please note that the information contained in the Prospectuses may be addressed to and/or targeted at persons who are residents of particular countries only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offers contained in the Prospectuses are not addressed. Prior to relying on the information contained in the Prospectuses, you must ascertain from the Prospectuses whether or not you are one of the intended addressees of the information contained therein.

The Notes will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or any U.S. state securities laws, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be only offered and sold to non-U.S. persons in offshore transactions outside the United States in accordance with Regulation S under the Securities Act.

Stabilisation in respect of the Notes may be conducted in accordance with FCA and International Capital Market Association Rules.


About Bupa

Bupa's purpose is helping people live longer, healthier, happier lives. With no shareholders, our customers are our focus. We reinvest profits into providing more and better healthcare for the benefit of current and future customers.

Health insurance accounts for the major part of our business with 17.5m customers and contributes 73% of revenue. We operate clinics, dental centres and hospitals in some markets, with 15.8m customers. We care for around 22,000 residents in our aged care businesses in the UK, Australia, New Zealand and Spain.

We directly employ around 83,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong, Turkey, Brazil, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.

For more information, visit www.bupa.com.

ajax-loader